FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

36322911000001109: Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Viatris UK Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2112901000001112 Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Viatris UK Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2112921000001117 Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Viatris UK Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Viatris UK Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 3 (CD No Register) true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Viatris UK Healthcare Ltd) Has specific active ingredient Naloxone hydrochloride dihydrate true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Viatris UK Healthcare Ltd) Is a Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Viatris UK Healthcare Ltd) Has active ingredient Naloxone true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Viatris UK Healthcare Ltd) Has active ingredient Buprenorphine true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Viatris UK Healthcare Ltd) Has manufactured dose form Conventional release sublingual tablet true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Viatris UK Healthcare Ltd) Has basis of strength substance Naloxone true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Viatris UK Healthcare Ltd) Has basis of strength substance Buprenorphine true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Viatris UK Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Viatris UK Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Viatris UK Healthcare Ltd) Has specific active ingredient Buprenorphine hydrochloride true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Viatris UK Healthcare Ltd) Has specific active ingredient Naloxone hydrochloride dihydrate false Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Viatris UK Healthcare Ltd) Has dispensed dose form Conventional release sublingual tablet true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Naloxone false Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Buprenorphine true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Viatris UK Healthcare Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Viatris UK Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Viatris UK Healthcare Ltd) 28 tablet 4 x 7 tablets Has AMP True Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start